Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LYPRESSIN Cause Lung opacity? 19 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Lung opacity have been filed in association with LYPRESSIN. This represents 29.7% of all adverse event reports for LYPRESSIN.

19
Reports of Lung opacity with LYPRESSIN
29.7%
of all LYPRESSIN reports
19
Deaths
19
Hospitalizations

How Dangerous Is Lung opacity From LYPRESSIN?

Of the 19 reports, 19 (100.0%) resulted in death, 19 (100.0%) required hospitalization, and 19 (100.0%) were considered life-threatening.

Is Lung opacity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LYPRESSIN. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does LYPRESSIN Cause?

Abdominal distension (51) Vomiting (51) Abdominal pain (50) Appendicitis (50) Ascites (50) Condition aggravated (50) Hyponatraemia (50) Off label use (50) Sepsis (50) Somnolence (50)

What Other Drugs Cause Lung opacity?

ALBUTEROL (296) PREDNISONE (216) TIOTROPIUM (196) LANSOPRAZOLE (166) IPRATROPIUM (157) ACETAMINOPHEN (153) MEPOLIZUMAB (149) PANTOPRAZOLE (140) BUDESONIDE\FORMOTEROL (139) MONTELUKAST (137)

Related Pages

LYPRESSIN Full Profile All Lung opacity Reports All Drugs Causing Lung opacity LYPRESSIN Demographics